American Association for the Study of Liver Diseases
David Suhy is presenting at this meeting on November 1-5th. Stock already got a good boost from International Symposium for the Study of Liver Disorders in Melbourne. Lot of good news lately and looks like professionals in the field are responding well to information being presented.
Benitec is flying under the radar ... this recent updraft should be only the beginning. Multiply market cap by 10 would still scream BARGAIN! in my mho. ARWR's recent pps explosion on the back of their first human HBV trials is a good indicator what is in store for Benitec once their one shot HCV trials get started next month. Benitec's HBV candidate will be validated by a successful HCV PHase I. I don't mind Benitec flying low profile for now as this provides the opp'ty to accumulate bonanza priced shares.